In addition, £2.5 million will better support pharmacists and patients by improving access to treatment and advice for a range of common ailments.
Yn ogystal, bydd £2.5 miliwn yn cefnogi fferyllwyr a chleifion drwy wella mynediad at driniaeth a chyngor ar gyfer ystod o anhwylderau cyffredin.